[Single dose of 24 Gy or 3-fraction SBRT regimen in the treatment of oligometastatic cancer? : A phase III multi-center trial].
Options
BORIS DOI
Publisher DOI
PubMed ID
34189598
Date of Publication
2021-09
Publication Type
Article
Subject(s)
Language(s)
de
Additional Credits
Series
Strahlentherapie und Onkologie
Publisher
Springer
ISSN
1439-099X
Access(Rights)
restricted